Hirano T
J Diabetes Investig. 2025; 16(3):370-383.
PMID: 39778086
PMC: 11871407.
DOI: 10.1111/jdi.14398.
Hirano T
J Atheroscler Thromb. 2024; 32(2):253-264.
PMID: 39231648
PMC: 11802249.
DOI: 10.5551/jat.65164.
Kim M, Zheng Z
Trends Endocrinol Metab. 2024; 36(3):278-291.
PMID: 39191606
PMC: 11861388.
DOI: 10.1016/j.tem.2024.07.020.
Gijbels A, Erdos B, Trouwborst I, Jardon K, Adriaens M, Goossens G
Cardiovasc Diabetol. 2024; 23(1):97.
PMID: 38493102
PMC: 10944619.
DOI: 10.1186/s12933-024-02188-0.
Gorji M, Alaei-Shahmiri F, Darban Hosseini Amirkhiz G, Sezavar S, Malek M, Khamseh M
Arch Iran Med. 2024; 26(6):290-299.
PMID: 38310429
PMC: 10685836.
DOI: 10.34172/aim.2023.45.
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
Tsilingiris D, Vallianou N, Spyrou N, Kounatidis D, Christodoulatos G, Karampela I
Curr Obes Rep. 2023; 13(1):1-34.
PMID: 38159164
PMC: 10933194.
DOI: 10.1007/s13679-023-00542-z.
Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production.
Yildirim V, Ter Horst K, Gilijamse P, van Harskamp D, Schierbeek H, Jansen H
JCI Insight. 2023; 8(16).
PMID: 37432744
PMC: 10543721.
DOI: 10.1172/jci.insight.166905.
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk.
Keirns B, Sciarrillo C, Koemel N, Emerson S
J Nutr Sci. 2021; 10:e75.
PMID: 34589207
PMC: 8453457.
DOI: 10.1017/jns.2021.73.
The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction.
Jones B, Sands C, Alexiadou K, Minnion J, Tharakan G, Behary P
J Clin Endocrinol Metab. 2021; 107(2):e767-e782.
PMID: 34460933
PMC: 8764224.
DOI: 10.1210/clinem/dgab608.
Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity.
Lytle K, Bush N, Triay J, Kellogg T, Kendrick M, Swain J
J Clin Endocrinol Metab. 2019; 104(12):6171-6181.
PMID: 31408176
PMC: 6821207.
DOI: 10.1210/jc.2019-00875.
Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb. 2018; 25(9):771-782.
PMID: 29998913
PMC: 6143775.
DOI: 10.5551/jat.RV17023.
Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.
Johansen R, Sondergaard E, Sorensen L, Jurik A, Christiansen J, Nielsen S
Diabetologia. 2016; 59(4):833-43.
PMID: 26781548
DOI: 10.1007/s00125-015-3856-5.
Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women.
Hodson L, Banerjee R, Rial B, Arlt W, Adiels M, Boren J
J Am Heart Assoc. 2015; 4(10):e002258.
PMID: 26432801
PMC: 4845132.
DOI: 10.1161/JAHA.115.002258.
Chronic hepatitis C virus infection and lipoprotein metabolism.
Aizawa Y, Seki N, Nagano T, Abe H
World J Gastroenterol. 2015; 21(36):10299-313.
PMID: 26420957
PMC: 4579877.
DOI: 10.3748/wjg.v21.i36.10299.
Is there a relation between triglyceride concentrations in very low density lipoprotein and the index of insulin resistance in nondiabetic subjects?.
Kurosaki Y, Tsukushi T, Munekata S, Kanoh Y, Moriya T, Nishinari M
J Clin Lab Anal. 2014; 28(4):269-74.
PMID: 24578003
PMC: 6807640.
DOI: 10.1002/jcla.21677.
The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level.
Kanda E, Ai M, Okazaki M, Maeda Y, Sasaki S, Yoshida M
BMC Nephrol. 2013; 14:212.
PMID: 24093487
PMC: 3853217.
DOI: 10.1186/1471-2369-14-212.
Systemic free fatty acid disposal into very low-density lipoprotein triglycerides.
Koutsari C, Mundi M, Ali A, Patterson B, Jensen M
Diabetes. 2013; 62(7):2386-95.
PMID: 23434937
PMC: 3712051.
DOI: 10.2337/db12-1557.
Lipoprotein particle distribution and skeletal muscle lipoprotein lipase activity after acute exercise.
Harrison M, Moyna N, Zderic T, OGorman D, McCaffrey N, Carson B
Lipids Health Dis. 2012; 11:64.
PMID: 22672707
PMC: 3393608.
DOI: 10.1186/1476-511X-11-64.
Hepatic ABCA1 and VLDL triglyceride production.
Liu M, Chung S, Shelness G, Parks J
Biochim Biophys Acta. 2011; 1821(5):770-7.
PMID: 22001232
PMC: 3272310.
DOI: 10.1016/j.bbalip.2011.09.020.
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.
Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K
J Gastroenterol. 2010; 46(1):101-7.
PMID: 20658156
DOI: 10.1007/s00535-010-0291-8.